NCT04850898View on ClinicalTrials.gov

Study of SAB-176 in Healthy Adult Participants

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

June 23, 2021

Primary Completion Date

October 8, 2021

Study Completion Date

October 8, 2021

Conditions
Influenza A H1N1
Interventions
BIOLOGICAL

SAB-176

Treatment of influenza

OTHER

Placebo

Placebo Control

Trial Locations (1)

E1 2AX

Queen Mary BioEnterprises Innovation Centre, London

Sponsors

Collaborators (1)

Hvivo
All Listed Sponsors
collaborator

Hvivo

INDUSTRY

lead

SAb Biotherapeutics, Inc.

INDUSTRY

NCT04850898 - Study of SAB-176 in Healthy Adult Participants | Biotech Hunter | Biotech Hunter